Literature DB >> 7245794

Total and proximal gastrectomy in the treatment of gastric carcinoma: a series of 305 cases.

M V Inberg, R Heinonen, P Laurén, V Rantakokko, S J Viikari.   

Abstract

Entities:  

Mesh:

Year:  1981        PMID: 7245794     DOI: 10.1007/bf01658304

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  19 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Results of surgery in the treatment of gastric cancer. A clinical study of 987 cases.

Authors:  S J VIIKARI; A HYTTINEN; V AUTIO; P VUORINEN
Journal:  Ann Chir Gynaecol Fenn Suppl       Date:  1962

3.  The relative survival rate: a statistical methodology.

Authors:  F EDERER; L M AXTELL; S J CUTLER
Journal:  Natl Cancer Inst Monogr       Date:  1961-09

4.  Aanastomotic leakage after excision of esophageal and high gastric carcinoma.

Authors:  M V Inberg; M I Linna; T M Scheinin; E Vänttinen
Journal:  Am J Surg       Date:  1971-10       Impact factor: 2.565

5.  Gastric and pancreatic function and the absorption of iron, vitamin B12, and calcium after proximal gastric resection for cancer in the upper part of the stomach.

Authors:  K Fischermann; H Mouridsen; I Neesgaard; H Worning; A Zacho
Journal:  Scand J Gastroenterol       Date:  1969       Impact factor: 2.423

6.  [Results of total gastrectomy in stomach cancer].

Authors:  T Maki
Journal:  Langenbecks Arch Chir       Date:  1969

7.  [The treatment of stomach cancer by total gastrectomy. Indications, technic and results].

Authors:  G Hegemann; F Gall
Journal:  Dtsch Med Wochenschr       Date:  1968-02-23       Impact factor: 0.628

8.  Partial or total gastrectomy for adenocarcinoma of the cardia.

Authors:  N G Kock; E Lewin; S Pettersson
Journal:  Acta Chir Scand       Date:  1969

9.  Surgical treatment of gastric carcinoma: a regional study of 2,590 patients over a 27-year period.

Authors:  M V Inberg; R Heinonen; V Rantakokko; S J Viikari
Journal:  Arch Surg       Date:  1975-06

10.  Trends in prognosis and surgical treatment of cancer of the stomach.

Authors:  W H ReMine; J T Priestley
Journal:  Ann Surg       Date:  1966-05       Impact factor: 12.969

View more
  6 in total

1.  Long-term results of proximal and total gastrectomy for adenocarcinoma of the upper third of the stomach.

Authors:  Chang Hak Yoo; Byung Ho Sohn; Won Kon Han; Won Kil Pae
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

2.  Healing of esophagojejunal anastomoses after experimental total gastrectomy. A comparative study using manually sutured or stapled anastomoses.

Authors:  B Walther; P Löwenhielm; S E Strand; F Ståhlberg; B Uvelius; J Oscarson; A Evander
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

3.  Evaluation of the safety and efficacy of esophagojejunostomy after totally laparoscopic total gastrectomy using a trans-orally inserted anvil: a single-center comparative study.

Authors:  Hiroaki Ito; Haruhiro Inoue; Noriko Odaka; Hitoshi Satodate; Manabu Onimaru; Haruo Ikeda; Daisuke Takayanagi; Kenta Nakahara; Shin-ei Kudo
Journal:  Surg Endosc       Date:  2014-02-01       Impact factor: 4.584

4.  The operative indications for proximal gastrectomy in patients with gastric cancer in the upper third of the stomach.

Authors:  K Kitamura; T Yamaguchi; S Nishida; K Yamamoto; D Ichikawa; K Okamoto; H Taniguchi; A Hagiwara; K Sawai; T Takahashi
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

5.  [Gastrectomy in the aged].

Authors:  R Bittner; M Butters; H Schirrow; W Krautzberger; H G Beger
Journal:  Langenbecks Arch Chir       Date:  1984

6.  Experiences with the linear cutter technique for performing Roux-en-Y anastomosis following total gastrectomy.

Authors:  Y Shoji; Z Nihei; R Hirayama; Y Mishima
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.